This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1994-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pocking-Possenhofen, DE (1994)
- Poecking/Possenhofen, DE (1996)
Company Filing History:
Years Active: 1994-1996
Title: Reinhard Herz: Innovator in Coagulation Parameter Determination
Introduction
Reinhard Herz is a notable inventor based in Munich, Germany. He has made significant contributions to the field of coagulation testing, holding 2 patents that enhance the accuracy and efficiency of medical diagnostics.
Latest Patents
His latest patents include a method for the determination of coagulation parameters. This innovative method involves a reaction cascade where thrombin catalyzes the formation of a fibrin clot from fibrin monomers. An inhibitor of F XIII is added, allowing the reaction vessel to be reused multiple times for coagulation tests. Another significant patent is for a method and reagent for the determination of antithrombin III. This method reacts the sample with thrombin and a chromogenic substrate, which forms a color through the action of thrombin. The reaction is conducted in the presence of denaturing agents or the tetrapeptide Gly-Pro-Arg-Pro, utilizing an oligopeptide substrate that is significantly more sensitive to thrombin.
Career Highlights
Reinhard Herz is associated with Boehringer Mannheim GmbH, where he has contributed to advancements in medical technology. His work has been pivotal in improving diagnostic methods in the healthcare sector.
Collaborations
He has collaborated with notable colleagues such as Andreas Dessauer and Ulrike Gebert, further enhancing the impact of his innovations.
Conclusion
Reinhard Herz's contributions to the field of coagulation testing exemplify the importance of innovation in medical diagnostics. His patents not only improve testing methods but also pave the way for future advancements in healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
